TrialBone marrow transplantation2005
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
X-J Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it